MarketCap
Facebook
X
Telegram
Aptinyx Operating Cycle | APTX
Annual Operating Cycle Aptinyx
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 46.9 | 81.8 | 50.8 | 42.1 | 34.5 | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 81.8 | 34.5 | 51.2 |
Quarterly Operating Cycle Aptinyx
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 11.7 | - | 91.2 | 47.9 | 39.1 | - | 43.3 | 43.8 | 52.4 | - | 55.9 | 24.8 | 28.1 | - | 71 | 29.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 91.2 | 11.7 | 44.9 |
Operating Cycle of other stocks in the Biotechnology industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Vaccinex
VCNX
|
546 | - | -61.37 % | $ 654 K |  USA |
 |
Nymox Pharmaceutical Corporation
NYMX
|
17.9 | - | -19.68 % | $ 18.4 M |  Canada |
 |
Pliant Therapeutics
PLRX
|
229 | $ 0.78 | -0.57 % | $ 47.9 M | USA |
 |
Jounce Therapeutics
JNCE
|
2.32 | - | - | $ 98.4 M | USA |
 |
Puma Biotechnology
PBYI
|
113 | $ 8.09 | -0.61 % | $ 405 M | USA |
 |
Acorda Therapeutics
ACOR
|
394 | - | -24.86 % | $ 820 K | USA |
 |
Omeros Corporation
OMER
|
599 | $ 18.08 | 4.86 % | $ 1.15 B | USA |
 |
Regeneron Pharmaceuticals
REGN
|
152 | $ 959.08 | 4.7 % | $ 100 B | USA |
 |
CymaBay Therapeutics
CBAY
|
175 | - | - | $ 3.45 B | USA |
 |
Timber Pharmaceuticals
TMBR
|
1.61 | - | - | $ 717 K | USA |
 |
G1 Therapeutics
GTHX
|
52.6 | - | - | $ 370 M | USA |
 |
Theravance Biopharma
TBPH
|
64.5 | $ 17.03 | 0.03 % | $ 857 M |  Cayman-islands |
 |
Chimerix
CMRX
|
52.5 | - | - | $ 756 M | USA |
 |
Sol-Gel Technologies Ltd.
SLGL
|
52.4 | $ 63.72 | 3.61 % | $ 178 M |  Israel |
 |
LogicBio Therapeutics
LOGC
|
9.88 | - | - | $ 229 M | USA |
 |
RedHill Biopharma Ltd.
RDHL
|
55.4 | $ 0.38 | 0.77 % | $ 4.68 B | Israel |
 |
Sanofi
SNY
|
330 | $ 48.42 | 0.38 % | $ 59.1 B |  France |
 |
Seagen
SGEN
|
362 | - | - | $ 42.2 B | USA |
 |
Baudax Bio
BXRX
|
256 | - | 0.59 % | $ 63 K | USA |
 |
ChemoCentryx
CCXI
|
43.2 | - | - | $ 3.74 B | USA |
 |
Avid Bioservices
CDMO
|
148 | - | - | $ 789 M | USA |
 |
Zosano Pharma Corporation
ZSAN
|
33.9 | - | 7.23 % | $ 2.72 M | USA |
 |
Spectrum Pharmaceuticals
SPPI
|
1.17 K | - | - | $ 189 M | USA |
 |
Alpine Immune Sciences
ALPN
|
1.73 | - | - | $ 2.17 B | USA |
 |
Berkeley Lights
BLI
|
349 | - | -7.31 % | $ 87 M | USA |
 |
VBI Vaccines
VBIV
|
1.98 | - | -50.87 % | $ 1.09 M | USA |
 |
CTI BioPharma Corp.
CTIC
|
90.1 | - | - | $ 1.2 B | USA |
 |
IVERIC bio
ISEE
|
2.41 | - | - | $ 5.51 B | USA |